Form 4: RODGERS STEVEN E reports acquisition/exercise transactions in AVAH

Q: What insider transaction did Aveanna Healthcare (AVAH) report for Steven E. Rodgers?

Aveanna Healthcare reported that director Steven E. Rodgers received a grant of 18,916 shares of common stock on February 14, 2026 . The transaction is coded as a grant or award rather than a market purchase, at a stated price of $0 per share .

Q: How many Aveanna Healthcare (AVAH) shares does Steven E. Rodgers own after this Form 4?

After the reported grant, director Steven E. Rodgers beneficially owns 312,414 shares of Aveanna common stock. The filing shows this amount as directly held, indicating it is recorded under his direct ownership following the February 14, 2026 equity award.

Q: Was the Aveanna Healthcare (AVAH) Form 4 transaction a stock purchase or a grant?

The Form 4 shows the Aveanna transaction as a grant or award , not a stock purchase. It is coded “A” for acquisition, with 18,916 shares received at $0 per share , reflecting a compensation-related equity grant to director Steven E. Rodgers.

Q: What are the vesting terms of Steven E. Rodgers’ Aveanna (AVAH) equity award?

The award is described as a grant of stock-settled restricted stock units subject to one-year cliff vesting . This means the full RSU grant is scheduled to vest at once after one year, rather than vesting in smaller periodic installments over time.

Q: What type of security did Steven E. Rodgers receive from Aveanna Healthcare (AVAH)?

Steven E. Rodgers received stock-settled restricted stock units linked to Aveanna’s common stock, par value $0.01 per share . Table I shows 18,916 common shares acquired, and the footnote clarifies they are delivered through stock-settled restricted stock units with a one-year cliff vest.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

RODGERS STEVEN E reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 18,916 shares. Following the reported transactions, holdings were 312,414 shares.

Insider Trade Summary

Net Buyer: 18,916 shares

Net Buy 1 txn

Insider RODGERS STEVEN E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	18,916	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 312,414 shares (Direct)

Footnotes (1)

F1. Grant of stock-settled restricted stock unit, subject to one-year cliff vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/17/2026 - 05:30 PM

FAQ

What insider transaction did Aveanna Healthcare (AVAH) report for Steven E. Rodgers?

Aveanna Healthcare reported that director Steven E. Rodgers received a grant of 18,916 shares of common stock on February 14, 2026. The transaction is coded as a grant or award rather than a market purchase, at a stated price of $0 per share.

How many Aveanna Healthcare (AVAH) shares does Steven E. Rodgers own after this Form 4?

After the reported grant, director Steven E. Rodgers beneficially owns 312,414 shares of Aveanna common stock. The filing shows this amount as directly held, indicating it is recorded under his direct ownership following the February 14, 2026 equity award.

Was the Aveanna Healthcare (AVAH) Form 4 transaction a stock purchase or a grant?

The Form 4 shows the Aveanna transaction as a grant or award, not a stock purchase. It is coded “A” for acquisition, with 18,916 shares received at $0 per share, reflecting a compensation-related equity grant to director Steven E. Rodgers.

What are the vesting terms of Steven E. Rodgers’ Aveanna (AVAH) equity award?

The award is described as a grant of stock-settled restricted stock units subject to one-year cliff vesting. This means the full RSU grant is scheduled to vest at once after one year, rather than vesting in smaller periodic installments over time.

What type of security did Steven E. Rodgers receive from Aveanna Healthcare (AVAH)?

Steven E. Rodgers received stock-settled restricted stock units linked to Aveanna’s common stock, par value $0.01 per share. Table I shows 18,916 common shares acquired, and the footnote clarifies they are delivered through stock-settled restricted stock units with a one-year cliff vest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RODGERS STEVEN E

(Last)

(First)

(Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA

30339

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	02/14/2026		A		18,916⁽¹⁾	A	$0	312,414	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of stock-settled restricted stock unit, subject to one-year cliff vesting.

	/s/ Jonathan Beckler, Attorney-in-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR